Insider sells 14952 shares of $PACB: Read remarks from Quiver Quantitative

Michele Farmer, identified as the See Remarks of $PACB, recently divested 14,952 shares of the company on 02-18-2026, fetching an estimated sum of $24,356. This transaction was reported through a recent SEC filing, representing a sale of about 6.4% of their holdings in this particular class of stock. Following this transaction, their ownership now stands at 219,092 shares of this class of $PACB stock.

Tracking the insider trading activity of $PACB, it has been noted that insiders have engaged in two transactions involving $PACB stock on the open market within the past 6 months. Out of these transactions, none have been acquisitions, while two have been sales. Looking closely at the recent trading patterns of $PACB stock by insiders over the last 6 months, Michele Farmer (See Remarks) has exhibited no acquisitions but has executed two sales, divesting a total of 50,167 shares for approximately $79,855.

On the hedge fund front, there have been notable moves in $PACB stock by institutional investors. In the latest quarter, 109 institutional investors have added shares of $PACB stock to their portfolios, while 102 have reduced their positions. Some of the most significant recent moves in $PACB stock include Edmond de Rothschild Holding S.A. removing 10,675,200 shares (-100.0%) from their portfolio in Q4 2025, valuing it at an estimated $19,962,624. On the other hand, Ark Investment Management LLC added 6,340,125 shares (+20.5%) to their portfolio in the same period, amounting to an estimated $11,856,033.

In terms of revenue, $PACB reported revenues of $2.8 million in Q4 2024, reflecting a decrease of -6.97% compared to the corresponding period in the previous year. For more details on PACB financials, interested parties can visit Quiver Quantitative’s PACB stock page for comprehensive information.

When it comes to analyst ratings, Wall Street analysts have recently issued reports on $PACB. Among these reports, one firm has assigned a buy rating to the stock, with no sell ratings being issued. Noteworthy analyst ratings include Stephens & Co. issuing an “Overweight” rating on 11/10/2025. Those keen on tracking analyst ratings and price targets for $PACB can explore Quiver Quantitative’s $PACB forecast page for detailed insights.

Multiple analysts have put forth price targets for $PACB in recent times. Over the last 6 months, three analysts have provided price targets for $PACB, with a median target of $2.0. Some of the recent targets include Luke Sergott from Barclays setting a target price of $2.0 on 12/15/2025, David Westenberg from Piper Sandler also setting a target price of $2.0 on 11/11/2025, and Mason Carrico from Stephens & Co. setting a target price of $2.0 on 11/10/2025.

It is essential to note that the information provided in this article is not intended as financial advice. Readers are advised to refer to Quiver Quantitative’s disclaimers for further details and clarification.